510(k) approval for Radionics' AtlasPlan software system:
This article was originally published in Clinica
The FDA has cleared Radionics' AtlasPlan, a software system designed to guide neurosurgeons in the planning of functional procedures on the brain. It allows fine-tuning of target co-ordinates, determining the anatomical extent of the target boundaries and planning the optimal trajectory. The image is translated and scaled down to match the patient image sets from CT or MR images, therefore accommodating different brain sizes. AtlasPlan is part of Radionics' NeuroPlan system.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.